Raphael Pharmaceutical Stock Probability of Future OTC Stock Price Finishing Over 10.79
| RAPH Stock | 0.26 0.00 0.00% |
Raphael |
Raphael Pharmaceutical Target Price Odds to finish over 10.79
The tendency of Raphael OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over 10.79 or more in 90 days |
| 0.26 | 90 days | 10.79 | close to zero percent |
Based on a normal probability distribution, the odds of Raphael Pharmaceutical to move over 10.79 or more in 90 days from now is close to zero percent (This Raphael Pharmaceutical probability density function shows the probability of Raphael OTC Stock to fall within a particular range of prices over 90 days) . Probability of Raphael Pharmaceutical price to stay between its current price of 0.26 and 10.79 at the end of the 90-day period is about 82.34 .
Given the investment horizon of 90 days the otc stock has the beta coefficient of 2.68 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Raphael Pharmaceutical will likely underperform. Additionally Raphael Pharmaceutical has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Raphael Pharmaceutical Price Density |
| Price |
Predictive Modules for Raphael Pharmaceutical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Raphael Pharmaceutical. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Raphael Pharmaceutical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Raphael Pharmaceutical is not an exception. The market had few large corrections towards the Raphael Pharmaceutical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Raphael Pharmaceutical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Raphael Pharmaceutical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.59 | |
β | Beta against Dow Jones | 2.68 | |
σ | Overall volatility | 0.70 | |
Ir | Information ratio | -0.14 |
Raphael Pharmaceutical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Raphael Pharmaceutical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Raphael Pharmaceutical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Raphael Pharmaceutical generated a negative expected return over the last 90 days | |
| Raphael Pharmaceutical has high historical volatility and very poor performance | |
| Raphael Pharmaceutical has some characteristics of a very speculative penny stock | |
| Raphael Pharmaceutical has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (1.62 B) with profit before overhead, payroll, taxes, and interest of 0. | |
| Raphael Pharmaceutical generates negative cash flow from operations |
Raphael Pharmaceutical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Raphael OTC Stock often depends not only on the future outlook of the current and potential Raphael Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Raphael Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 15.5 M |
Raphael Pharmaceutical Technical Analysis
Raphael Pharmaceutical's future price can be derived by breaking down and analyzing its technical indicators over time. Raphael OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Raphael Pharmaceutical. In general, you should focus on analyzing Raphael OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Raphael Pharmaceutical Predictive Forecast Models
Raphael Pharmaceutical's time-series forecasting models is one of many Raphael Pharmaceutical's otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Raphael Pharmaceutical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Raphael Pharmaceutical
Checking the ongoing alerts about Raphael Pharmaceutical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Raphael Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Raphael Pharmaceutical generated a negative expected return over the last 90 days | |
| Raphael Pharmaceutical has high historical volatility and very poor performance | |
| Raphael Pharmaceutical has some characteristics of a very speculative penny stock | |
| Raphael Pharmaceutical has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (1.62 B) with profit before overhead, payroll, taxes, and interest of 0. | |
| Raphael Pharmaceutical generates negative cash flow from operations |
Other Information on Investing in Raphael OTC Stock
Raphael Pharmaceutical financial ratios help investors to determine whether Raphael OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Raphael with respect to the benefits of owning Raphael Pharmaceutical security.